Harraz, M M <br/><br/>
Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation.  [electronic resource] 

 -  Molecular psychiatry  Mar 2016 
 - 313-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1476-5578 
<br/><br/><label>Standard No.: </label>10.1038/mp.2015.211  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antidepressive Agents--pharmacology<br/>Cells, Cultured<br/>Cerebral Cortex--cytology<br/>Cysteine--analogs & derivatives<br/>Depression--drug therapy<br/>Disease Models, Animal<br/>Embryo, Mammalian<br/>Exploratory Behavior--drug effects<br/>Female<br/>Gene Expression Regulation--drug effects<br/>HEK293 Cells<br/>Humans<br/>Ketamine--pharmacology<br/>Male<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Monomeric GTP-Binding Proteins--genetics<br/>N-Methylaspartate--pharmacology<br/>Neurons--drug effects<br/>Neuropeptides--genetics<br/>Nitric Oxide--genetics<br/>Nitric Oxide Synthase Type I--deficiency<br/>Nitric Oxide Synthase Type II--deficiency<br/>Pregnancy<br/>Proteolysis--drug effects<br/>Ras Homolog Enriched in Brain Protein<br/>S-Nitrosothiols--pharmacology<br/>Signal Transduction--drug effects<br/>Swimming--psychology<br/>TOR Serine-Threonine Kinases--genetics<br/>Time Factors